HGF and neoplasm: Given that HGF is a well-known prognostic factor for MM progression and acts as pro-survival cytokine for MM tumor cells [32], it is likely that in human clinical trials HGF neutralization will add further anti-proliferative potential to MP0250 antiangiogenic effect.